＊CONTOUR（R）NEXT ONE BGMSがOmnipod Dash（TM）PDMと接続 Ascensia Diabetes Careは8日、Omnipod（R）インスリン管理システム（Omnipod System ...

Ascensia Diabetes Care has announced it has entered into a strategic alliance by signing a development agreement with Insulet Corporation, the leader in tubeless insulin pump technology with its ...

＊CONTOUR（R）NEXT ONE BGMSがOmnipod Dash（TM）PDMと接続 Ascensia Diabetes Careは8日、Omnipod（R）インスリン管理システム（Omnipod System）によるチューブレス・インスリンポンプ（リンク）技術のリーダーであるInsulet Corporation （NASDAQ: PODD）と開発契約に署名し戦略的提携 ...

Insulet Corporation PODD continues to gain on solid prospects in the diabetes market. The company is progressing well with respect to its four-pillar strategy. Yet, macroeconomic woes exert ...

Insulet has secured US Food and Drug Administration (FDA) clearance for an algorithm advancement within its Omnipod 5 automated insulin delivery (AID) system, setting users up with tighter insulin ...

* INSULET CORP - ANNOUNCED A VOLUNTARY MEDICAL DEVICE CORRECTION FOR ALL OMNIPOD DASH™ PERSONAL DIABETES MANAGERS DISTRIBUTED GLOBALLY Source text for Eikon: Further company coverage: ...

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received FDA 510(k) ...